Idelvion
Payments companies reported to CMS as associated with Idelvion. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Idelvion, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Idelvion
These are the largest totals companies reported as associated with Idelvion. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mindy Simpson | Chicago, IL | Pediatrics | $43,216.18 |
| Tammuella Chrisentery-Singleton | New Orleans, LA | Pediatric Hematology-Oncology | $24,396.42 |
| Richard Lemons | Salt Lake City, UT | Pediatric Hematology-Oncology | $20,381.59 |
| Lynn Malec | Milwaukee, WI | Pediatric Hematology-Oncology | $18,323.84 |
| Miguel Escobar | Houston, TX | Hematology (Internal Medicine) | $13,658.30 |
| Patricia Amerson | San Antonio, TX | Pediatrics (Nurse Practitioner) | $11,215.11 |
| Maria Velez-Yanguas | New Orleans, LA | Pediatric Hematology-Oncology | $11,042.74 |
| Lindsey Greene | Philadelphia, PA | Pediatric Hematology-Oncology | $10,655.73 |
| Guy Young | Bozeman, MT | Pediatric Hematology-Oncology | $9,853.22 |
| Clay Cohen | Houston, TX | Pediatric Hematology-Oncology | $7,995.27 |
Prescribed Idelvion?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.